e.g. Tata motors, Reliance MF, 500570

Genomic Valley Biotech Ltd.

539206  GVBL   Group (X)

17 Apr,12:15
28.50 -1.40 (-4.68%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
BSE  |  NSE
zoomZoomRefresh
Day
Wk
Mn
6Mn
Yr
Volume

80

Prev close

29.90

Day's H/L (Rs.)

28.50 - 28.50

52wk H/L (Rs.)

64.00 - 20.10

Mkt Cap (Rs. Cr)

8.84

Genomic Valley Biotech Ltd.

InvestChart

Genomic Valley Biotech Ltd. is not listed on NSE (View BSE)

Financial Results of Genomic Valley Biotech Ltd.

(Rs. Crore)
Mar ' 25Mar ' 24Mar ' 23Mar ' 22Mar ' 21
Sales0.840.172.720.070.21
Operating profit0.440.010.88-0.38-0.14
Interest---0.040.18
Gross profit0.440.020.92-0.34-0.31
EPS (Rs)1.170.052.12-0.03-1.83

See More >

Compare 'Genomic Valley Biotech Ltd.' with other stocks

  • Syngene International Ltd.
  • 434.70
  • Compare
  • Jubilant Ingrevia Ltd.
  • 667.80
  • Compare
  • Jain Irrigation Systems Ltd.
  • 34.21
  • Compare
  • Kaveri Seed Company Ltd.
  • 920.65
  • Compare

Statements:

Balance Sheet  |  P&L  |  Cash Flow  |  Dividend  |  Bonus  |  Share Holding  |  Capital Structures  |  Ratios

Genomic Valley Biotech Ltd. PERFORMANCE SNAPSHOT

If you had invested Rs.
in Genomic Valley Biotech Ltd.,
  ago

You would have Rs. 000.00

Add to Portfolio

Report Card

PE Ratios
24.45
EPS (Rs.)
1.17
Sales (Rs. Cr)
0.05
Face Value (Rs.)
10
Net Profit Margin (%)
42.19
Last Bonus
Last Dividend (%)
Return on Average Equity
9.13

Frequently Asked Questions

Q: What is the current share price of Genomic Valley Biotech Ltd.?

A: The current share price of Genomic Valley Biotech Ltd. is ₹ 28.50 (for BSE as on 17 Apr,12:15). The 52-week range is ₹ 64.00 - 20.10. Prices are updated based on live market data.

Q: What is the market capitalization of Genomic Valley Biotech Ltd.?

A: Genomic Valley Biotech Ltd. has a market capitalization of ₹ 8.84 Cr, making it a company.

Q: What is the PE ratio of Genomic Valley Biotech Ltd.?

A: The Price-to-Earnings (PE) ratio of Genomic Valley Biotech Ltd. is 24.45, indicating its valuation relative to earnings.

Q: Is Genomic Valley Biotech Ltd. a good investment?

A: Genomic Valley Biotech Ltd. is considered based on its financial performance, sector outlook, and market conditions. Investors should evaluate fundamentals and consult financial advisors before investing.

Q: What are the latest financial results of Genomic Valley Biotech Ltd.?

A: Genomic Valley Biotech Ltd. has reported its latest annual results with revenue of ₹ 0.84 and net profit/loss of ₹ 0.36.

Close
Add Genomic Valley Biotech Ltd. to your Portfolio
 
 
     
 
Close
Add Genomic Valley Biotech Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback